An official website of the United States government Here's how you know

The .gov means it's official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

New Drug Application (NDA): 203231
Company: INFORLIFE

Products on NDA 203231

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	TE Code	RLD	RS
ZOLEDRONIC ACID	ZOLEDRONIC ACID	EQ 4MG BASE/100ML	INJECTABLE;INTRAVENOUS	Prescription	AP	Yes	Yes

Approval Date(s) and History, Letters, Labels, Reviews for NDA 203231

Original Approvals or Tentative Approvals

Action Date	Submission	Action Type	Submission Classification	Review Priority; Orphan Status	Letters, Reviews, Labels, Patient Package Insert	Notes	Url
08/02/2013	ORIG-1	Approval	Type 5 - New Formulation or New Manufacturer	STANDARD	Label (PDF) Letter (PDF) Letter (PDF) Review		https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/203231s000lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2013/203231Orig1s000ltr.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2012/203231Orig1s000TAltr.pdf https://www.accessdata.fda.gov/drugsatfda_docs/nda/2013/203231Orig1s000TOC.html

Supplements

Action Date	Submission	Supplement Categories or Approval Type	Letters, Reviews, Labels, Patient Package Insert	Note	Url
04/05/2022	SUPPL-19	Labeling-Container/Carton Labels, Labeling-Package Insert	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/203231Orig1s019Lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2022/203231Orig1s019ltr.pdf
10/27/2020	SUPPL-17	Labeling-Package Insert	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/203231s015s016s017lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2020/203231Orig1s015,s016,s017ltr.pdf
10/27/2020	SUPPL-16	Labeling-Package Insert	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/203231s015s016s017lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2020/203231Orig1s015,s016,s017ltr.pdf
10/27/2020	SUPPL-15	Labeling-Package Insert	Letter (PDF)	Label is not available on this site.	https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2020/203231Orig1s015,s016,s017ltr.pdf
02/02/2017	SUPPL-13	Labeling-Package Insert	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/203231s013lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2017/203231Orig1s013ltr.pdf
03/25/2016	SUPPL-11	Labeling-Package Insert	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/203231s011lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2016/203231Orig1s011ltr.pdf
10/08/2015	SUPPL-10	Labeling-Package Insert	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/203231s010lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2015/203231Orig1s010ltr.pdf
08/31/2015	SUPPL-9	Manufacturing (CMC)		Label is not available on this site.
08/31/2015	SUPPL-8	Manufacturing (CMC)		Label is not available on this site.
12/10/2014	SUPPL-7	Labeling-Package Insert	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/203231s005s006s007lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2014/203231Orig1s005,s006,s007ltr.pdf
12/10/2014	SUPPL-6	Labeling-Package Insert	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/203231s005s006s007lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2014/203231Orig1s005,s006,s007ltr.pdf
12/10/2014	SUPPL-5	Labeling-Package Insert	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/203231s005s006s007lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2014/203231Orig1s005,s006,s007ltr.pdf
03/11/2014	SUPPL-4	Manufacturing (CMC)		Label is not available on this site.
05/02/2014	SUPPL-2	Labeling-Package Insert	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/203231s002lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2014/203231Orig1s002ltr.pdf
02/07/2014	SUPPL-1	Manufacturing (CMC)		Label is not available on this site.

Labels for NDA 203231

Action Date	Submission	Supplement Categories or Approval Type	Letters, Reviews, Labels, Patient Package Insert	Note	Url
04/05/2022	SUPPL-19	Labeling-Container/Carton Labels	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/203231Orig1s019Lbl.pdf
04/05/2022	SUPPL-19	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/203231Orig1s019Lbl.pdf
10/27/2020	SUPPL-17	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/203231s015s016s017lbl.pdf
10/27/2020	SUPPL-16	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/203231s015s016s017lbl.pdf
02/02/2017	SUPPL-13	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/203231s013lbl.pdf
03/25/2016	SUPPL-11	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/203231s011lbl.pdf
10/08/2015	SUPPL-10	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/203231s010lbl.pdf
12/10/2014	SUPPL-7	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/203231s005s006s007lbl.pdf
12/10/2014	SUPPL-6	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/203231s005s006s007lbl.pdf
12/10/2014	SUPPL-5	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/203231s005s006s007lbl.pdf
05/02/2014	SUPPL-2	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/203231s002lbl.pdf
08/02/2013	ORIG-1	Approval	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/203231s000lbl.pdf

Therapeutic Equivalents for NDA 203231

ZOLEDRONIC ACID

INJECTABLE;INTRAVENOUS; EQ 4MG BASE/100ML
TE Code = AP

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	RLD	TE Code	Application No.	Company
ZOLEDRONIC	ZOLEDRONIC ACID	EQ 4MG BASE/100ML	INJECTABLE;INTRAVENOUS	Prescription	No	AP	205749	GLAND
ZOLEDRONIC ACID	ZOLEDRONIC ACID	EQ 4MG BASE/100ML	INJECTABLE;INTRAVENOUS	Prescription	No	AP	210174	AMNEAL
ZOLEDRONIC ACID	ZOLEDRONIC ACID	EQ 4MG BASE/100ML	INJECTABLE;INTRAVENOUS	Prescription	No	AP	219984	GLAND
ZOLEDRONIC ACID	ZOLEDRONIC ACID	EQ 4MG BASE/100ML	INJECTABLE;INTRAVENOUS	Prescription	Yes	AP	203231	INFORLIFE

Top